Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of engineered cartilage based on BMSCs and chondrocytes seeded on PVA-PPU scaffold in a sheep model.
Taghizadehjahed M, Sepahdar A, Rabiee N, Nazbar A, Farzad-Mohajeri S, Dehghan MM, Shokrgozar MA, Majidi M, Mardjanmehr SH, Aminianfar H, Akbari Javar H, Bonakdar S. Taghizadehjahed M, et al. Among authors: aminianfar h. J Biomed Mater Res B Appl Biomater. 2022 Nov;110(11):2411-2421. doi: 10.1002/jbm.b.35087. Epub 2022 May 19. J Biomed Mater Res B Appl Biomater. 2022. PMID: 35587251
Evaluating osteogenic potential of a 3D-printed bioceramic-based scaffold for critical-sized defect treatment: an in vivo and in vitro investigation.
Safiaghdam H, Baniameri S, Aminianfar H, Mohajeri SF, Dehghan MM, Tayebi L, Nokhbatolfoghahaei H, Khojasteh A. Safiaghdam H, et al. Among authors: aminianfar h. In Vitro Cell Dev Biol Anim. 2024 Jun;60(6):657-666. doi: 10.1007/s11626-024-00912-4. Epub 2024 May 14. In Vitro Cell Dev Biol Anim. 2024. PMID: 38743380
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates.
Zamani P, Mashreghi M, Rezazade Bazaz M, Zargari S, Alizadeh F, Dorrigiv M, Abdoli A, Aminianfar H, Hatamipour M, Zarqi J, Behboodifar S, Samsami Y, Khorshid Sokhangouy S, Sefidbakht Y, Uskoković V, Rezayat SM, Jaafari MR, Mozaffari-Jovin S. Zamani P, et al. Among authors: aminianfar h. J Control Release. 2023 Aug;360:316-334. doi: 10.1016/j.jconrel.2023.06.025. Epub 2023 Jul 5. J Control Release. 2023. PMID: 37355212
Novel therapeutic approach to slow down the inflammatory cascade in acute/subacute spinal cord injury: Early immune therapy with lipopolysaccharide enhanced neuroprotective effect of combinational therapy of granulocyte colony-stimulating factor and bone-marrow mesenchymal stem cell in spinal cord injury.
Hashemizadeh S, Hosseindoost S, Omidi A, Aminianfar H, Ebrahimi-Barough S, Ai J, Arjmand B, Hadjighassem M. Hashemizadeh S, et al. Among authors: aminianfar h. Front Cell Neurosci. 2022 Nov 23;16:993019. doi: 10.3389/fncel.2022.993019. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36505513 Free PMC article.
3D-printed MgO nanoparticle loaded polycaprolactone β-tricalcium phosphate composite scaffold for bone tissue engineering applications: In-vitro and in-vivo evaluation.
Safiaghdam H, Nokhbatolfoghahaei H, Farzad-Mohajeri S, Dehghan MM, Farajpour H, Aminianfar H, Bakhtiari Z, Jabbari Fakhr M, Hosseinzadeh S, Khojasteh A. Safiaghdam H, et al. Among authors: aminianfar h. J Biomed Mater Res A. 2023 Mar;111(3):322-339. doi: 10.1002/jbm.a.37465. Epub 2022 Nov 5. J Biomed Mater Res A. 2023. PMID: 36334300